NCT06037096 Implementation of a Structured Post-pulmonary Embolism Follow-up Model
| NCT ID | NCT06037096 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Aalborg University Hospital |
| Condition | Pulmonary Embolism |
| Study Type | INTERVENTIONAL |
| Enrollment | 2,000 participants |
| Start Date | 2022-03-15 |
| Primary Completion | 2026-03 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 2,000 participants in total. It began in 2022-03-15 with a primary completion date of 2026-03.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Venous thromboembolism (VTE), clinically presenting as deep vein thrombosis or pulmonary embolism (PE) is the third most frequent cardiovascular disease and is associated with substantial short- and long-term morbidity and mortality and high costs of care. In addition negative physical and mental complications following VTE are common. However in terms of PE, there are no structured follow-up programs in Denmark and there is considerable variation in practice patterns of post-PE management both within and between countries. This project aims to develop, test and implement a structured follow-up care model for patients with PE (The Attend-PE model). This project is a pre-post intervention study and will estimate the effectiveness of implementing the structured follow-up care model on a national level.
Eligibility Criteria
Inclusion Criteria: * adult patients (≥18 years) * CT-verified diagnosis of PE Exclusion Criteria: * patients who are not living in Denmark on the extraction date * patients with a active cancer
Contact & Investigator
Anette A. Højen
PRINCIPAL INVESTIGATOR
Aalborg University Hospital
Frequently Asked Questions
Who can join the NCT06037096 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Pulmonary Embolism. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06037096 currently recruiting?
Yes, NCT06037096 is actively recruiting participants. Contact the research team at a.wind@rn.dk for enrollment information.
Where is the NCT06037096 trial being conducted?
This trial is being conducted at Aalborg, Denmark.
Who is sponsoring the NCT06037096 clinical trial?
NCT06037096 is sponsored by Aalborg University Hospital. The principal investigator is Anette A. Højen at Aalborg University Hospital. The trial plans to enroll 2,000 participants.